Document is current
Any future updates will be listed below
-
Authors
Scurr, Martin J. https://orcid.org/0000-0002-4120-0688
Lippiatt, George
Capitani, Lorenzo
Bentley, Kirsten https://orcid.org/0000-0002-6619-2098
Lauder, Sarah N.
Smart, Kathryn
Somerville, Michelle S.
Rees, Tara
Stanton, Richard J. https://orcid.org/0000-0002-6799-1182
Gallimore, Awen
Hindley, James P.
Godkin, Andrew https://orcid.org/0000-0002-1910-7567
-
Funding
Funding for this research was provided by:
Innovate UK (10007867)
RCUK | Medical Research Council (MR/V028448/1, MR/S00971X/1, MR/V028448/1)
Cancer Research UK (C16731/A21200, C16731/A21200)
Wellcome Trust (209213/Z/17/Z)
Cancer Research Wales
UKRI (UK Research Institute) - COVID-19 National Core Study Immunity programme grant
- License Information
-
More Information
Article History
Received: 15 July 2022
Accepted: 25 August 2022
First Online: 21 September 2022
Competing interests
: M.J.S and An.G are founders of and hold equity in ImmunoServ Ltd. J.P.H. holds equity in ImmunoServ Ltd. G.L. and T.R. are employees of ImmunoServ Ltd. All other authors declare no competing interests.
